Department of Clinical Pharmacy and Pharmacology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
Department of Anaesthesiology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
PLoS One. 2022 Aug 25;17(8):e0273370. doi: 10.1371/journal.pone.0273370. eCollection 2022.
Data substantiating the optimal patient body temperature during cooling procedures in cardiac operations are currently unavailable. To explore the optimal temperature strategy, we examined the association between temperature management and survival among patients during cardiopulmonary bypass assisted coronary artery bypass grafting (CABG) procedures on 30-days and 5-year postoperative survival. Adult patients (n = 5,672, 23.6% female and mean (SD) age of 66 (10) years) operated between 1997 and 2015 were included, with continuous measured intraoperative nasopharyngeal temperatures. The association between mortality and patient characteristics, laboratory parameters, the lowest intraoperative plateau temperature and intraoperative cooling/rewarming rates were examined by multivariate Cox regression analysis. Machine learning-based cluster analysis was used to identify patient subgroups based on pre-cooling parameters and explore whether specific subgroups benefitted from a particular temperature management. Mild hypothermia (32-35°C) was independently associated with improved 30-days and 5-year survival compared to patients in other temperature categories regardless of operation year. 30 days and 5-year survival were 98% and 88% in the mild hypothermia group, whereas it amounted 93% and 80% in the severe hypothermia (<30°C). Normothermia (35-37°C) showed the lowest survival after 30 days and 5 years amounting 93% and 72%, respectively. Cluster analysis identified 8 distinct patient subgroups principally defined by gender, age, kidney function and weight. The full cohort and all patient subgroups displayed the highest survival at a temperature of 32°C. Given these associations, further prospective randomized controlled trials are needed to ascertain optimal patient temperatures during CPB.
目前尚无数据支持心脏手术中冷却过程中患者的最佳体温。为了探索最佳温度策略,我们研究了体外循环辅助冠状动脉旁路移植术(CABG)期间患者的体温管理与 30 天和 5 年术后生存率之间的关系。纳入了 1997 年至 2015 年间接受手术的成年患者(n=5672,23.6%为女性,平均年龄(SD)为 66(10)岁),术中连续测量鼻咽温度。通过多变量 Cox 回归分析,检查死亡率与患者特征、实验室参数、最低术中平台温度和术中冷却/复温率之间的关系。基于预冷却参数,使用基于机器学习的聚类分析来识别患者亚组,并探讨特定亚组是否受益于特定的体温管理。与其他温度组别的患者相比,轻度低温(32-35°C)与 30 天和 5 年生存率的提高独立相关,无论手术年份如何。轻度低温组的 30 天和 5 年生存率分别为 98%和 88%,而严重低温组(<30°C)分别为 93%和 80%。正常体温(35-37°C)在 30 天后和 5 年后的生存率最低,分别为 93%和 72%。聚类分析确定了 8 个不同的患者亚组,主要由性别、年龄、肾功能和体重定义。整个队列和所有患者亚组在 32°C 时显示出最高的生存率。鉴于这些关联,需要进一步进行前瞻性随机对照试验,以确定体外循环期间患者的最佳体温。